Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1994-04-29
1995-11-21
Jordan, Kimberly R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
424 49, 514635, A61K 31195, A61K 31155, A61K 716
Patent
active
054687772
ABSTRACT:
The present invention relates to methods and agents for preventing and reversing the staining of teeth caused by the nonenzymatic browning of proteins in the oral cavity. Suitable agents for the inhibition of nonenzymatic browning may be formulated as rinses and toothpastes, and include cysteine and cysteine derivatives. These preparations may further include known anti-plaque agents, such as chlorhexidine.
REFERENCES:
patent: 3055882 (1962-09-01), Mull et al.
patent: 3055883 (1962-09-01), Mull et al.
patent: 3098066 (1963-07-01), Mull et al.
patent: 3101336 (1963-08-01), James et al.
patent: 3178433 (1965-04-01), Mull et al.
patent: 3506680 (1970-04-01), Berger et al.
patent: 3637850 (1972-01-01), Houlihan et al.
patent: 3681504 (1972-08-01), Johnston et al.
patent: 3746764 (1973-07-01), Nordmann et al.
patent: 4665192 (1987-05-01), Cerami
patent: 4758583 (1988-07-01), Cerami et al.
patent: 4908446 (1990-03-01), Ulrich et al.
patent: 4978684 (1990-12-01), Cerami et al.
patent: 4983604 (1991-01-01), Ulrich et al.
patent: 5096703 (1992-03-01), Cerami et al.
patent: 5128122 (1992-07-01), Cerami et al.
patent: 5286480 (1994-02-01), Boggs et al.
patent: 5334617 (1994-08-01), Ulrich et al.
Martindale, The Extra Pharmacopoeia, 28th Ed., The Pharmaceutical Press, 1982, pp. 50 and 554-556.
Bain. 1980. "Chlorhexidine in dentistry--a review," New Zealand Dental Journal. 76: 49-54.
Baylin et al. 1975. "Increase in food consumption and growth after treatment with aminoguanidine." Experientia 31: 562-4.
Beavin et al. 1969. "A specific and sensitive assay for aminoguanidine: its application to a study of the disposition of aminoguanidine in animal tissues." J. Pharm Exp. Ther. 165: 14-22.
Brown et al. 1990. "Aminoguanidine prevents cataracts in the nephrectomized alloxan--induced diabetic rabbit," J. Am. Soc. Nephrol. 1(4): 329, 8P.
Brownlee. 1989. "Pharmacological modulation of the advanced glycosylation reaction." Chem. Abstracts 111: 70141f.
Brownlee et al. 1988 "Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications," No. Eng. J. Med. 318: 1315-21.
Brownlee et al. 1986. "Inhibition of glucose--derived protein crosslinking and prevention of early diabetic changes in glomerular basement membrane by aminoguanidine." Diabetes 35, supp. 1: 42A, 166.
Brownlee et al. 1986. "Aminoguanidine prevents diabetes--induced arterial wall protein cross-linking," Science 232: 1629-32.
Brownlee et al. 1985. "Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein," Diabetes 34: 938-41.
Brownlee et al. 1984. "Nonenzymatic glycosylation and the pathogenesis of diabetic complications", Ann. Int. Med. 101: 527-37.
Brownlee et al. 1983. "Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen," J. Exp. Med. 158: 1730-1744.
Bunn et al. 1975. "Further identification of the nature and linkage of the carbohydrate in hemoglobin A.sub.1c. " Biochem. Biophys. Res. Comm. 67: 103-9.
Cameron et al. 1992. "Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin--diabetic rats." Diabetologia 35: 946-50.
Carroll et al. 1984. "Dose--dependent inhibition of aortic albumin in diabetes by alpha--hydrazinohistidine." Fed. Proc. 43: 2514.
Ceriello et al. 1985. "Acetylsalicylic acid amd lysine inhibit protein glycosylation in vitro." Chem. Abstracts 103: 115893f.
Dabrowski et al. 1984. "Alterations in histamine and collagen induced in chick embryos by aminoguanidine and 48/80." Agents and Actions 14: 458-60.
Dabrowski et al. 1983. "The effects of the stimulation of histamine-forming capacity (HFC) and the inhibition of histamine catabolism on tensile and collagen content of skin wounds in the rats." Acta. Physiol. Pol. 34: 91-7.
Eble et al. 1983. "Nonenzymatic glucosylation and glucose-dependent cross-linking of protein." J. Biol. Chem. 258: 9406-12.
Geisen, 1987. "Influence of aminoguanidine on cataract development in streptozotocin-diabetic rats." Akt. Endocrin. Stoffw. 8: 78.
Giambrone and Brownlee. 1989. "Aminoguanidine treatment normalizes increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozocin-diabetic rats." Diabetes 38, Supp. 2: 83 A.
Godfrey. 1962. "The synthesis of heterocyclic compounds from urea derivitives." Doctoral Dissertation. University of London.
Harding. 1985. "Nonenzymatic covalent posttranslational modification of proteins in vivo." Advances in Protein Biochemistry 37: 247-334.
Hauase et al. 1989. "Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo." J. Biol. Chem. 263: 3758-64.
Hollis and Strickberger. 1985. "Inhibition of aortic histamine synthesis by alpha-hydrazinohistadine inhibits increased aortic albumin accumulation in experimental diabetes in the rat." Diabetologia 28: 282-5.
Hollis et al. 1095. "Changes in plasma histamine concentration in the streptozotocin-diabetic rat." Exp. Molec. Path. 43: 90-6.
Hollis et al. 1984. "Time-dependent changes in aortic albumin permeability characteristics in experimental diabetes." Exp. Molec. Path. 41: 207-17.
Hollis et al. 1984. "Aortic albumin accumulation in diabetes and hypertension and its alteration by alpha-hydrozinahistidine, insulin and hypertension reversal." Fed. Proc.43: 714, 2513.
Hull. 1980. "Chemical inhibition of plaque." J. Clin. Periodont. 7: 431-42.
Khatami et al. 1988. "Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation." Chem. Abstracts 110: 643b.
Kihara et al. 1991. "Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals." Proc. Natl. Acad. Sic. USA 88: 6107-6111.
Kohn et al. 1984. "Collagen aging in vitro by nonenzymatic glycosylation and browning." Diabetes 33: 57-9.
Kumari et al. 1991. "Inhibition of diabetes-associated complications by nucleophilic compounds," Diabetes 40: 1079-84.
Lehninger. 1981. "Proteins: three-dimentional conformation," Biochemistry: The Molecular Basis of Cell Structure and Function. 2nd ed pp. 135-6.
Levine and Watts. 1966. "A sensitive and specific assay for histidine decarboxylase activity." Biochem. Pharmac. 15: 841-9.
Levine and Noll. "Histidine decarboxylase and its inhibition." Ann. N.Y. Acad. Sci. : 246-56 (1969).
Lewis and Harding. 1990. "The effects of aminoguanidine on the glycation (non-dnzymic glycosylation) of lens proteins." Exp. Eye Res. 50: 463-67.
Lindberg and Tornqvist. 1966. "The inhibitory effect of aminoguanidine on histamine catabolism in human pregnancy." Acta. Obst. Gyn Scand. 45: 131-9.
Lubec et al. 1990. "The effect of substance L on glucose-mediated cross-links of collagen in the diabetic db/db mouse." Nephron 56: 281-4.
Merck Index. 1989. 11th ed. entry #'s 441, 453, 2787, 5509, 6826, 7029.
Merck Index. 1983. 10th ed. entry #444.
Merck Index. 1976. 9th ed. entry #'s 447, 4676.
Monnier et al. 1984. "Accelerated age-related browning of human collagen in diabetes mellitus." Proc. Natl. Acad. Sci. USA 81: 583-7.
Monnier and Cerami. 1981. "Nonezymatic browning in vivo: possible process for aging of long-lived proteins." Science 211: 491-3.
Nakamura et al. 1991. "Prevention and reversible solubilization of advanced glycation and products (AGE) by organic germanium compounds as derivitives of amino acids." Amino Acids 1: 263-78.
Nicholls and Mandel. 1989. "Advanced glycosylation end-products in experimental murine diabetic nephropathy." Lab. Invest. 60: 486-91.
Nordbo. 1978. "Ability of chlorhexidine and benzalkonium chloride to catalyze browning reactions in vivo." J. Dent. Res. 58: 1429.
Odetti et al. 1990. "Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin." Diabetes 39: 796-801.
Oimomi et al. 1989 Letter to the editor re: Aminoguanidine inhibits 3-deoxyglucosone during the advnced Maillard reaction. Diabetes Res. Clin. Prac. `6: 311-3.
Oimomi et al. 1989 "The effects of aminoguanidine on 3-deoxyblocosone in the Maillard reaction." Agric. Biol. Chem. 53: 1727-8.
Onada et al. "Inhibitors (e.
Cerami Anthony
France Dennis S.
Neer David L.
Norton Laura A.
Ulrich Peter C.
Alteon Inc.
Jordan Kimberly R.
The Rockefeller University
LandOfFree
Method and agents for preventing and reversing the staining of t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and agents for preventing and reversing the staining of t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and agents for preventing and reversing the staining of t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137534